Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2025-12-25 @ 12:26 AM
NCT ID:
NCT06013358
Eligibility Criteria:
Inclusion Criteria:
* Recipients aged 18 and above
* Patients with de novo DSA positivity post-kidney transplantation and stable renal function: De novo HLA DSAs encompass both class I and class II, with Mean Fluorescence Intensity (MFI) greater than 1000. Stable renal function is defined as serum creatinine variation of less than 15% compared to the last 6 months.
* Patients with detected de novo HLA-DSAs but did not undergo histological examinations.
Exclusion Criteria:
* Multi-organ transplant recipients
* Recipients with positive preformed DSAs
* ABO-incompatible transplant recipients
* Pediatric recipients under 18 years old at the time of transplantation
* Recipients lost to follow-up observation
* atients already subjected to histological examinations due to positive De novo HLA-DSAs.
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06013358
Study Brief:
Protocol Section:
NCT06013358